Table 2 Correlation between clinicopathological variables and FCR.
Variables | FCR low | FCR high | P-value | |
---|---|---|---|---|
(N = 44, 72.1%) | (N = 17, 27.9%) | |||
Age median, (range) | 67 (45–85) | 67.5 (45–85) | 67.0 (51–83) | 0.750b |
Sex | Female (N = 27) | 19 (70.4) | 8 (29.6) | 1 |
Male (N = 34) | 25 (73.5) | 9 (26.5) | ||
HBs-Ag | Positive (N = 7) | 4 (57.1) | 3 (42.9) | 0.393 |
Negative (N = 53) | 39 (73.6) | 14 (26.4) | ||
HCV-Ab | Positive (N = 5) | 4 (80.0) | 1 (20.0) | 1 |
Negative (N = 55) | 39 (70.9) | 16 (29.1) | ||
Morphology | MF (N = 39) | 29 (74.4) | 10 (25.6) | 0.767 |
MF + PI (N = 22) | 15 (68.2) | 7 (31.8) | ||
Differentiation | Well (N = 9) | 8 (88.9) | 1 (11.1) | 0.423 |
Moderate (N = 39) | 25 (64.1) | 14 (35.9) | ||
Poor (N = 9) | 7 (77.8) | 2 (22.2) | ||
Others (N = 2) | 2 (100.0) | 0 (0.0) | ||
Tumour location | Hilar (N = 36) | 27 (75.0) | 9 (25.0) | 0.574 |
Peripheral (N = 25) | 17 (68.0) | 8 (32.0) | ||
Tumour size | ≦5 cm (N = 34) | 26 (76.5) | 8 (23.5) | 0.566 |
>5 cm (N = 27) | 18 (66.7) | 9 (33.3) | ||
Tumour number | Single (N = 44) | 32 (72.7) | 12 (27.3) | 1 |
Multiple (N = 17) | 12 (70.6) | 5 (29.4) | ||
Vascular invasiona | Positive (N = 32) | 22 (68.7) | 10 (31.3) | 0.746 |
Negative (N = 16) | 12 (66.7) | 4 (33.3) | ||
Serosal invasion | Positive (N = 30) | 20 (77.4) | 7 (22.6) | 0.402 |
Negative (N = 31) | 24 (66.7) | 10 (33.3) | ||
Lymph node metastasis | Presense (N = 23) | 14 (60.9) | 9 (39.1) | 0.045 |
Absense (N = 25) | 22 (88.0) | 3 (12.0) | ||
Undetermined (N = 13) | ||||
Distant metastasis | Presense (N = 4) | 4 (100.0) | 0 (0.0) | 0.569 |
Absense (N = 57) | 40 (70.2) | 17 (29.8) | ||
Preoperative | ≦37 U/ml (N = 23) | 18 (78.3) | 5 (21.7) | 0.539 |
Serum CA19-9 | >37 U/ml (N = 29) | 20 (69.0) | 9 (31.0) | |
Preoperative | ≦5 ng/ml (N = 38) | 30 (78.9) | 8 (21.1) | 0.182 |
Serum CEA | >5 ng/ml (N = 15) | 9 (60.0) | 6 (40.0) |